When completed in 2010, the 20000-square-foot facility on west campus will house startup companies based on KU research, other emerging technology businesses and collaborations involving KU researchers and large technology firms. For more information, visit: www.news.ku.edu
Posts Tagged ‘Business’
Bioscience & Technology Business Center groundbreaking
October 10th, 2009Ascential Bioscience Business Opportunity
August 27th, 2009www.cashbiz88.info Ascential Bioscience was established by professionals in the fields of nutrition, fitness, elite physical performance, and weight management, who have pooled their knowledge and expertise to create a system for creating positive change in the lives of those who are looking to improve body weight and composition, athletic performance, health status, and overall energy and vitality. Systems of Acential products have been created for specific application to health …
Ascential Bioscience Review: Scam? Or Legitimate MLM?
June 27th, 2009www.HeartHealthyChocolates.com Ascential Bioscience is a business opportunity that is promoted through the network marketing home business industry. Before you join Ascential Bioscience, have you heard that several 6-figure income earning internet marketing phenoms have entered into a network marketing company in the beginning phases of critical mass and in only 4 Short Weeks.. Have Set Records Once Again…The Numbers? You’ll have to See It to believe it… No other time in the history of …
Virginia Bioscience Commercialization Center – Donna Edmonds
June 24th, 2009Donna Edmonds, Executive Director of Virginia Biosciences Commercialization Center, talks about bringing in new biotechnology and bioscience companies to Richmond, Virginia to further develop their products and research and bring them to market.
Scott Salka, CEO of Ambit Bioscience Works to Cure Cancer
June 12th, 2009As a cutting edge bioscience research facility, Ambit Bioscience is working hard to cure certain types of cancer through their knowledge of Kinases. In this bizSanDiego interview, Scott Salka, Ambit’s CEO, discusses Kinases and the companies progress.
